Literature DB >> 14977681

Myofibers express IL-6 after eccentric exercise.

Akihito Tomiya1, Toshimi Aizawa, Ryoichi Nagatomi, Hiroomi Sensui, Shoichi Kokubun.   

Abstract

BACKGROUND: Interleukin (IL)-6 is locally produced in skeletal muscles and shows a remarkable increase in plasma after eccentric exercises.
OBJECTIVE: To elucidate the cell types in the muscles responsible for IL-6 production after eccentric exercises. STUDY
DESIGN: Controlled laboratory study.
METHODS: An eccentric contraction model was made using electrical stimulation. The authors investigated the muscle damage and regeneration processes after eccentric exercises histologically, and the cell types expressing IL-6 and its subcellular compartimentalization with time immunohistochemically after eccentric exercises.
RESULTS: Swollen myofibers were detected from 8 hours to 3 days after exercises. Disrupted myofibers were detected from 24 hours to 7 days, with a peak of 3 days. IL-6 was detected only in the cytoplasm of myofibers until 12 hours; thereafter, it was found in the inflammatory cells and proliferating satellite cells as well. The swollen myofibers were negatively stained for IL-6. The positive ratios of IL-6 in myofibers immediately increased after exercises, peaked in 12 hours, and then decreased.
CONCLUSIONS: After eccentric exercises, IL-6 expression increased in myofibers preceding the disruption of myofibers. IL-6 might be closely related to muscle damage caused by strenuous exercises.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977681     DOI: 10.1177/0095399703258788

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  24 in total

Review 1.  The role of neutrophils in injury and repair following muscle stretch.

Authors:  Hechmi Toumi; Sleem F'guyer; Thomas M Best
Journal:  J Anat       Date:  2006-04       Impact factor: 2.610

2.  Eccentric exercise induces chronic alterations in musculoskeletal nociception in the rat.

Authors:  Pedro Alvarez; Jon D Levine; Paul G Green
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

Review 3.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 4.  Satellite cells and the muscle stem cell niche.

Authors:  Hang Yin; Feodor Price; Michael A Rudnicki
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

5.  Maternal obesity downregulates myogenesis and beta-catenin signaling in fetal skeletal muscle.

Authors:  Jun F Tong; Xu Yan; Mei J Zhu; Stephen P Ford; Peter W Nathanielsz; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-27       Impact factor: 4.310

6.  Differential genomic responses in old vs. young humans despite similar levels of modest muscle damage after resistance loading.

Authors:  Anna E Thalacker-Mercer; Louis J Dell'Italia; Xiangqin Cui; James M Cross; Marcas M Bamman
Journal:  Physiol Genomics       Date:  2009-11-10       Impact factor: 3.107

7.  Mechanisms mediating vibration-induced chronic musculoskeletal pain analyzed in the rat.

Authors:  Olayinka A Dina; Elizabeth K Joseph; Jon D Levine; Paul G Green
Journal:  J Pain       Date:  2009-12-03       Impact factor: 5.820

8.  Role of interleukin-6 in chronic muscle hyperalgesic priming.

Authors:  O A Dina; P G Green; J D Levine
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

9.  Eccentric contractions do not induce rhabdomyolysis in malignant hyperthermia susceptible mice.

Authors:  Benjamin T Corona; Clement Rouviere; Susan L Hamilton; Christopher P Ingalls
Journal:  J Appl Physiol (1985)       Date:  2008-09-11

10.  Association of interleukin-6 signalling with the muscle stem cell response following muscle-lengthening contractions in humans.

Authors:  Bryon R McKay; Michael De Lisio; Adam P W Johnston; Ciara E O'Reilly; Stuart M Phillips; Mark A Tarnopolsky; Gianni Parise
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.